Aravinda M De Silva

Title: Aravinda M De Silva: Innovator in Dengue Virus Research

Introduction

Aravinda M De Silva is a prominent inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of virology, particularly in the study of dengue viruses. Her innovative work has led to the development of a unique patent that addresses critical aspects of dengue virus research.

Latest Patents

Aravinda M De Silva holds a patent for "Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions." This invention provides compositions and methods of use that include a chimeric dengue virus E glycoprotein. The glycoprotein comprises a dengue virus E glycoprotein backbone, which features amino acid substitutions that introduce a dengue virus E glycoprotein domain I and domain II hinge region from a different dengue virus serotype. This innovative approach has the potential to enhance the understanding and treatment of dengue virus infections.

Career Highlights

Throughout her career, Aravinda has worked at esteemed institutions such as the University of North Carolina at Chapel Hill and Vanderbilt University. Her research has focused on the mechanisms of dengue virus infection and the development of effective vaccines. Her dedication to advancing scientific knowledge has made her a respected figure in her field.

Collaborations

Aravinda has collaborated with notable colleagues, including Wahala M P B Wahala and Ralph Baric. These partnerships have fostered a collaborative environment that encourages innovative research and the sharing of ideas.

Conclusion

Aravinda M De Silva's contributions to dengue virus research exemplify her commitment to innovation and scientific advancement. Her patent and collaborative efforts highlight her role as a leading inventor in the field.